Acorda Therapeutics Acquires Civitas Therapeutics for $525,000,000

  • Feed Type
  • Date
  • Company Name
    Civitas Therapeutics
  • Mailing Address
    190 Everett Ave. Chelsea, MA 02150 USA
  • Company Description
    Civitas is a pharmaceutical company focused on developing products with a clinically proven dry powder pulmonary delivery platform. The proprietary dry powder and device combination is unique in its ability to deliver a large, precise dose independent of inspiratory flow rate from a simple, passive device.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Acorda Therapeutics announced that it entered into an agreement to acquire Civitas Therapeutics, a privately-held biopharmaceutical company, for $525 million in cash.

Trending on Xconomy